Cargando…

The role of CDK5 and GSK3B kinases in hyperphosphorylation of microtubule associated protein tau (MAPT) in Alzheimer's disease

Alzheimer's disease is the most common form of dementia. Abnormal hyperphosphorylation of Microtubule associated protein tau (MAPT) is one of the hallmarks of Alzheimer's disease and related tau pathies. CDK5 and GSK3B are the two main protein kinases that have an important role in the abn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jayapalan, Saranya, Natarajan, Jeyakumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Biomedical Informatics 2013
Materias:	Hypothesis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910359/ https://www.ncbi.nlm.nih.gov/pubmed/24497730 http://dx.doi.org/10.6026/97320630091023

Ejemplares similares

Erratum: A numerical error in methodology section under Sequence retrieval and modeling side heading To: The role of CDK5 and GSK3B kinases in hyperphosphorylation of microtubule associated protein tau (MAPT) in Alzheimer’s disease
por: Jayapalan, Saranya, et al.
Publicado: (2014)

Kainic acid hyperphosphorylates tau via inflammasome activation in MAPT transgenic mice
por: Zheng, Xiang-Yu, et al.
Publicado: (2019)

Curcumin Downregulates GSK3 and Cdk5 in Scopolamine-Induced Alzheimer’s Disease Rats Abrogating Aβ(40/42) and Tau Hyperphosphorylation
por: Das, Tushar Kanti, et al.
Publicado: (2019)

Identification of potent inhibitors of microtubule affinity regulating kinase for inhibition of tau hyperphosphorylation
por: Levy, Alison, et al.
Publicado: (2013)

Computational identification and analysis of neurodegenerative disease associated protein kinases in hominid genomes
por: Jayapalan, Saranya, et al.
Publicado: (2016)

Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases
por: Duka, Valeriy, et al.
Publicado: (2013)

Functional gene clustering via gene annotation sentences, MeSH and GO keywords from biomedical literature
por: Natarajan, Jeyakumar, et al.
Publicado: (2007)

Computational genome analyses of metabolic enzymes in Mycobacterium leprae for drug target identification
por: Shanmugam, Anusuya, et al.
Publicado: (2010)

Microarray Data Analysis and Mining Tools
por: Selvaraj, Saravanakumar, et al.
Publicado: (2011)

Expression of Concern: Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases
Publicado: (2023)

Hyperphosphorylation of Tau Associates With Changes in Its Function Beyond Microtubule Stability
por: Alonso, Alejandra D., et al.
Publicado: (2018)

Truncation and activation of GSK-3β by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease
por: Jin, Nana, et al.
Publicado: (2015)

Role of the Long Non-Coding RNA MAPT-AS1 in Regulation of Microtubule Associated Protein Tau (MAPT) Expression in Parkinson's Disease
por: Coupland, Kirsten G., et al.
Publicado: (2016)

Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer’s disease
por: Zhang, Bei, et al.
Publicado: (2016)

Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer’s Disease Brain Pathology: Not All Tau Phospho-Sites are Hyperphosphorylated
por: Barthélemy, Nicolas R., et al.
Publicado: (2022)

Neurons derived from sporadic Alzheimer’s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation
por: Ochalek, Anna, et al.
Publicado: (2017)

Cellular polyamines condense hyperphosphorylated Tau, triggering Alzheimer’s disease
por: Ivanov, Stefan M., et al.
Publicado: (2020)

Hyperphosphorylation-Induced Tau Oligomers
por: Iqbal, Khalid, et al.
Publicado: (2013)

Morphometric alterations of Golgi apparatus in Alzheimer's disease are related to tau hyperphosphorylation
por: Antón-Fernández, Alejandro, et al.
Publicado: (2017)

Alzheimer’s disease: Ablating single master site abolishes tau hyperphosphorylation
por: Stefanoska, Kristie, et al.
Publicado: (2022)

Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes
por: Park, Susanna B, et al.
Publicado: (2014)

Vps35 Deficiency Impairs Cdk5/p35 Degradation and Promotes the Hyperphosphorylation of Tau Protein in Retinal Ganglion Cells
por: Gao, Ling, et al.
Publicado: (2020)

High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation
por: Azorsa, David O, et al.
Publicado: (2010)

GSK3β-mediated tau hyperphosphorylation triggers diabetic retinal neurodegeneration by disrupting synaptic and mitochondrial functions
por: Zhu, Huazhang, et al.
Publicado: (2018)

GSK-3β and ERK1/2 incongruously act in tau hyperphosphorylation in SPS-induced PTSD rats
por: Wei, Zhen, et al.
Publicado: (2019)

Differential Hyperphosphorylation of Tau-S199, -T231 and -S396 in Organotypic Brain Slices of Alzheimer Mice. A Model to Study Early Tau Hyperphosphorylation Using Okadaic Acid
por: Foidl, Bettina M., et al.
Publicado: (2018)

The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease
por: Liu, Zhenzhen, et al.
Publicado: (2015)

Effect of p62 on tau hyperphosphorylation in a rat model of Alzheimer's disease☆
por: Zheng, Xianhong, et al.
Publicado: (2012)

The Link Between Diabetes Mellitus and Tau Hyperphosphorylation: Implications for Risk of Alzheimer's Disease
por: Hobday, Amy L, et al.
Publicado: (2021)

Hyperphosphorylated tau mediates neuronal death by inducing necroptosis and inflammation in Alzheimer’s disease
por: Dong, Yue, et al.
Publicado: (2022)

Hypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors
por: Bretteville, Alexis, et al.
Publicado: (2012)

Pharmacophore feature-based virtual screening for finding potent GSK-3 inhibitors using molecular docking and dynamics simulations
por: Chauhan, Navneet, et al.
Publicado: (2016)

Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease
por: Refenes, Nikolaos, et al.
Publicado: (2009)

The M-phase specific hyperphosphorylation of Staufen2 involved the cyclin-dependent kinase CDK1
por: Beaujois, Rémy, et al.
Publicado: (2017)

Hippocampal phospho-tau/MAPT neuropathology in the fornix in Alzheimer disease: an immunohistochemical autopsy study
por: Plowey, Edward D., et al.
Publicado: (2016)

The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells
por: Ikeda, Hirokuni, et al.
Publicado: (2010)

The GSK3 kinase inhibitor lithium produces unexpected hyperphosphorylation of β-catenin, a GSK3 substrate, in human glioblastoma cells
por: Abdul, Ata ur Rahman Mohammed, et al.
Publicado: (2017)

Direct High Affinity Interaction between Aβ42 and GSK3α Stimulates Hyperphosphorylation of Tau. A New Molecular Link in Alzheimer’s Disease?
por: Dunning, Christopher J., et al.
Publicado: (2015)

Sulforaphene Ameliorates Neuroinflammation and Hyperphosphorylated Tau Protein via Regulating the PI3K/Akt/GSK-3β Pathway in Experimental Models of Alzheimer's Disease
por: Yang, Wen, et al.
Publicado: (2020)

In silico pharmacokinetic and molecular docking studies of small molecules derived from Indigofera aspalathoides Vahl targeting receptor tyrosine kinases
por: Paramashivam, Sathish Kumar, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kg4iufsm4mp0l9nvo7rrpgmksk